Symbol Lookup

Tuesday April 21, 2015 7:35 AM ET. Data delayed 15 minutes.
0.00
0.00 (0.00%)
Bid/Lots
0.00/100
Ask/Lots
0.05/100
Open/Prev Close
0.00/0.00
Day Range
-----
52-Week Range
0.00-0.03
Vol/Avg Daily Vol
0.0/146.3K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
No documents available

Company Information

Cambridge Heart, Inc. is a healthcare company engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company’s diagnostic products incorporate technology for the measurement of Microvolt T-Wave Alternans (MTWA), a subtle beat-to-beat fluctuation in the T-wave segment of the electrocardiogram (ECG), which is a marker of SCA risk. Microvolt T-Wave Alternans is a non-invasive, clinically-proven, reimbursable test that can help identify patients at risk for sudden cardiac arrest. MTWA technology is available on a number of platforms including the CH2000 and HearTwave II cardiac diagnostic systems. The Company’s products include HearTwave II system, CH2000, MTWA for Q-Stress and Micro-V Alternans Sensors. Cambridge Heart also offers a selection of accessories and supplies including treadmills, patient cables, printers, paper, and additional accessories.

CONTACT INFORMATION

Headquarters100 AMES POND ROAD
TEWKSBURY, MA, United States 1876
Phone978-654-7600
Fax978-752-1330

EXECUTIVE OFFICERS

President, Treasurer, Secretary, DirectorCraig Jalbert

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$170.2KBeta0.44
Revenue (TTM)$2.0MEPS$-0.06
Shares Out.100.1MBook Value$-0.13
Cambridge Heart Inc does not pay a dividend.P/E--
Price/Sales (TTM)0.1
P/Cash Flow (TTM)--
Operating Margin-260.02%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample